Volker Knappertz Insider Profile

4 Followers
Volker Knappertz, CMO at GW Pharma, holds 319.13K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 0.00 shares in GW Pharma (Ticker: GWPH). Most recently, Volker Knappertz Sold ― shares of Aurinia Pharmaceuticals on Feb 29, 2024 for an estimated value of 30.07K.
tipranks
Volker Knappertz

Volker Knappertz
GW Pharma (GWPH)
CMO

Ranked #91,115 out of 99,218 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-50.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Volker Knappertz's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
EVP, Research and Development
Roles that Volker Knappertz holds in companies

Most Profitable Insider Trade

Stock:
GW Pharma
(GWPH)
Rating:Informative Sell
Date:Mar 05, 2019 - Mar 05, 2020
Return:+42.50%
The most profitable trade made by Volker Knappertz

Volker Knappertz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GWPH
GW Pharma
May 07, 2021
Uninformative Sell
$0.00
Aurinia Pharmaceuticals
Feb 29, 2024
EVP, Research and Development
Informative Sell
30.07K
$2.34M
List of latest transactions for each holding click on a transaction to see Volker Knappertz's performance on stock

Volker Knappertz insider profile FAQ

What is the percentage of profitable transactions made by Volker Knappertz?
The percentage of profitable transactions made by Volker Knappertz is 25%.
    What is the average return per transaction made by Volker Knappertz?
    The average return per transaction made by Volker Knappertz is -50.70%.
      What stocks does Volker Knappertz hold?
      Volker Knappertz holds: GWPH, AUPH stocks.
        What was Volker Knappertz’s latest transaction?
        Volker Knappertz latest transaction was an Informative Sell of $30.07K.
          What was Volker Knappertz's most profitable transaction?
          Volker Knappertz’s most profitable transaction was an Informative Sell of GWPH stock on March 5, 2019. The return on the trade was 42.50%.
            What is Volker Knappertz's role in GW Pharma?
            Volker Knappertz's role in GW Pharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.